Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers of Naltrexone Response in Opioid Addiction
NCT02324725Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Oct 2011
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in opioid use disorder (OUD), sponsored by University of Pennsylvania. Started Oct 2011; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02324725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02324725.